Invention Grant
- Patent Title: Isoquinolinesulfonyl derivative as RHO kinase inhibitor
-
Application No.: US15306965Application Date: 2015-04-21
-
Publication No.: US09856264B2Publication Date: 2018-01-02
- Inventor: Lingyun Wu , Yuanshan Yao , Zhaoguo Chen , Shuhui Chen
- Applicant: MEDSHINE DISCOVERY INC.
- Applicant Address: CN Jiangsu
- Assignee: Medshine Discovery Inc.
- Current Assignee: Medshine Discovery Inc.
- Current Assignee Address: CN Jiangsu
- Agency: Harness, Dickey & Pierce, P.L.C.
- Priority: CN201410174893 20140428; CN201510182758 20150416
- International Application: PCT/CN2015/077045 WO 20150421
- International Announcement: WO2015/165341 WO 20151105
- Main IPC: A61K31/437
- IPC: A61K31/437 ; C07D487/04 ; A61K31/4725 ; A61K31/55 ; C07D401/12 ; C07D471/04
Abstract:
The present invention discloses a class of isoquinolinesulfonyl derivatives as RHO kinase inhibitors, and pharmaceutical compositions thereof, and relates to pharmaceutically acceptable uses thereof. Specifically, the present invention relates to a compound as represented by formula (I), or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US20170037050A1 ISOQUINOLINESULFONYL DERIVATIVE AS RHO KINASE INHIBITOR Public/Granted day:2017-02-09
Information query
IPC分类:
